No Financial Anything New? Disclosures Eric Wirtz, MD February - - PowerPoint PPT Presentation

▶

May 31, 2023 178 likes •274 views

Treatment of Larynx Cancer - Is There No Financial Anything New? Disclosures Eric Wirtz, MD February 15, 2020 VA Larynx Trial 39% of patients in chemotherapy group survived with functioning larynx Salvage laryngectomy 41% of

SLIDE 1

Treatment of Larynx Cancer - Is There Anything New?

Eric Wirtz, MD February 15, 2020

No Financial Disclosures

SLIDE 2

VA Larynx Trial

39% of patients in

chemotherapy group survived with functioning larynx

Salvage laryngectomy
41% of patients with fixed

vocal cords

44% of stage IV patients
56% of patients with T4

cancers

SLIDE 3

SLIDE 4

SLIDE 5

SLIDE 6

SLIDE 7

SLIDE 8

NCCN Guidelines Summary

T4 disease - Surgery + adjuvant therapy
T3 disease - ? Bioselection
T2/T1 disease - uni-modality treatment